Target Name: OR2G3
NCBI ID: G81469
Review Report on OR2G3 Target / Biomarker Content of Review Report on OR2G3 Target / Biomarker
OR2G3
Other Name(s): OR1-33 | Olfactory receptor family 2 subfamily G member 3 | OR2G3_HUMAN | OTTHUMP00000038361 | Olfactory receptor, family 2, subfamily G, member 3 | olfactory receptor OR1-33 | Olfactory receptor 2G3 | olfactory receptor family 2 subfamily G member 3 | Olfactory receptor OR1-33

OR2G3: A Potential Drug Target for Neurodegenerative Diseases

OR2G3 (OR1-33) is a protein that is expressed in the brain and is known for its role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The protein is composed of 210 amino acid residues and has a calculated pI of 1.95. OR2G3 is a member of the OR2G family of proteins, which are known for their roles in various cellular processes, including cell signaling and stress response.

OR2G3 is expressed in the brain and is highly targeted to specific cell types, including neurons and glial cells. It is involved in the development and progression of neurodegenerative diseases, and has been shown to play a role in the development of Alzheimer's disease and Parkinson's disease.

One of the key functions of OR2G3 is its role in the formation of neuroplasticity, which is the ability of the brain to change and adapt in response to new experiences or environments. OR2G3 is involved in the formation of neuroplasticity by promoting the production of new neurons and the formation of new neural connections.

In addition to its role in neuroplasticity, OR2G3 is also involved in the regulation of cellular stress. It has been shown to play a role in the regulation of cellular stress by promoting the production of stress-resistant proteins and by inhibiting the production of stress- deficient proteins.

OR2G3 is a potential drug target for the treatment of neurodegenerative diseases. Because it can regulate the growth and loss of neurons and glial cells, it is highly expressed in neurons and glial cells and is involved in the development of neurons and glial cells. and losses. By regulating the growth and loss of neurons and glial cells, OR2G3 may become a potential target for the treatment of neurodegenerative diseases.

In addition, OR2G3 is also related to neuronal apoptosis. Studies have shown that OR2G3 can inhibit neuronal apoptosis and promote neuronal survival. These findings suggest that OR2G3 may be a potential therapeutic target for neurodegenerative diseases.

OR2G3 is also a potential biomarker for the diagnosis and monitoring of neurodegenerative diseases. Because it can be used to detect neuronal death and neuronal damage, these changes can serve as important indicators for the diagnosis and treatment of neurodegenerative diseases.

In summary, OR2G3 is a protein that is involved in the development and progression of neurodegenerative diseases. Its role in neuroplasticity and cellular stress makes it a potential drug target and biomarker for the treatment of these diseases. Further research is needed to fully understand the role of OR2G3 in neurodegenerative diseases and to develop effective treatments.

Protein Name: Olfactory Receptor Family 2 Subfamily G Member 3

Functions: Odorant receptor

The "OR2G3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2G3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5